Delta wave activity disruption during sleep may be a useful metric to identify those at an increased risk for cardiovascular disease and mortality, a new study suggested.
Philips announced the main terms of an agreement it reached in January with the U.S. government on its new sleep apnea machines, which has already cost the company over 360.
A mandibular advancement device was non-inferior to standard of care CPAP to reduce blood pressure in patients with hypertension and sleep apnea in the CRESCENT trial.